Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and pharmacokinetics of AMG 986 in healthy volunteers and those with severe renal impairment; completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• AMG 986

Snippet

Sponsor: Amgen | Conditions: Heart Failure | Phase 1 | Status: COMPLETED | Results posted: 2021-01-27